US 7887812
Live attenuated Leishmania vaccines
granted A61KA61K2039/522A61K39/008
Quick answer
US patent 7887812 (Live attenuated Leishmania vaccines) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K2039/522, A61K39/008, A61P, A61P33/02